Literature DB >> 3318970

Almitrine bismesylate: current status.

J Tweney1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3318970

Source DB:  PubMed          Journal:  Bull Eur Physiopathol Respir        ISSN： 0395-3890


× No keyword cloud information.
  4 in total

1.  Metabolism of almitrine in extensive and poor metabolisers of debrisoquine/sparteine.

Authors:  A Herchuelz; D Gangji; F Derenne; J P Jeanniot; J Douchamps
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 2.  Prevention and management of drug-induced peripheral neuropathy.

Authors:  L L Olesen; T S Jensen
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

3.  Normotensive normoxic men undergoing water diuresis fail to respond to stimulation of their peripheral arterial chemoreceptors by almitrine with an increase in plasma concentrations of atrial natriuretic factor.

Authors:  C Ledderhos; W Quies; A Bub; R Sanchez
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

4.  Ventilatory, circulatory, endocrine, and renal effects of almitrine infusion in man: a contribution to high altitude physiology.

Authors:  E A Koller; M Schopen; M Keller; R E Lang; M B Vallotton
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.